{
  "document_id": "AimmuneTherapeuticsInc_20200205_8-K_EX-10.3_11967170_EX-10.3_Development Agreement",
  "file_path": "data/CUAD_v1/full_contract_pdf/Part_I/Development/AimmuneTherapeuticsInc_20200205_8-K_EX-10.3_11967170_EX-10.3_Development Agreement.pdf",
  "text_length": 167722,
  "chunk_count": 229,
  "vector_store_path": "output/vector_stores/AimmuneTherapeuticsInc_20200205_8-K_EX-10.3_11967170_EX-10.3_Development Agreement",
  "summary": "15.2 Entire Agreement\u037e Amendment. This Agreement, together with the Schedules and Exhibits hereto, contains the entire understanding of the\nParties with respect to the subject matter hereof. Any other express or implied agreements and understandings, negotiations, writings and commitments,\neither oral or written, in respect to the subject matter hereof are superseded by the terms of this Agreement. The Schedules and Exhibits to this\nAgreement are incorporated herein by reference and shall be deemed a part of this Agreement. This Agreement may be amended, or any term hereof\nmodified, only by a written instrument duly executed by authorized representatives of each of the Parties.\n15.3 Force Majeure. No Party shall be liable for any failure to perform, or be considered in breach of, its obligations under this Agreement (other\nthan obligations to make payments of money) to the extent such performance has been delayed, interfered with or prevented by an event of Force\n\nany remaining provisions hereof. The Parties shall make a good faith effort to replace any invalid or unenforceable provision with a valid and enforceable\none such that the objectives contemplated by the Parties when entering this Agreement may be realized.\n15.9 Cumulative Remedies.  No remedy referred to in this Agreement is intended to be exclusive, but each shall be cumulative and in addition to\nany other remedy referred to in this Agreement or otherwise available under Applicable Law.\n15.10  Ambiguities\u037e No Presumption.  Each of the Parties acknowledges and agrees that this Agreement has been diligently reviewed by and\nnegotiated by and between them, that in such negotiations each of them has been represented by competent counsel and that the final agreement\ncontained herein, including the language whereby it has been expressed, represents the joint efforts of the Parties hereto and their counsel. Accordingly,\n\nword \u201cshall\u201d, (d) any definition of or reference to any agreement, instrument or other document herein shall be construed as referring to such agreement,\ninstrument or other document as from time to time amended, supplemented or otherwise modified (subject to any restrictions on such amendments,\nsupplements or modifications set forth herein), (e) any reference herein to any person shall be construed to include the person\u2019s successors and assigns,\n(f) the words \u201cherein\u201d, \u201chereof\u201d and \u201chereunder\u201d, and words of similar import, shall be construed to refer to this Agreement in its entirety and not to any\nparticular provision hereof, (g) all references herein to Articles, Sections, Exhibits or Schedules shall be construed to refer to Articles, Sections, Exhibits\nor Schedules of this Agreement, and references to this Agreement include all Exhibits and Schedules hereto, (h) the word \u201cnotice\u201d means notice in writing\n\nof any costs incurred by the non-enforcing  or defending Party in providing such assistance.\n(iii) Aimmune shall not, without the prior written consent of Xencor ([***]), enter into [***] relating to any claim, suit or\naction that it brought under Section 9.4.2 involving a [***]. Xencor shall not, without the prior written consent of Aimmune ([***]), enter into any [***]\nrelating to any claim, suit or action that it brought under Section 9.4.2 involving an [***].\n(iv) Any settlements, damages or other monetary awards (a \u201cRecovery \u201d) recovered pursuant to a suit, action or proceeding\nbrought pursuant to Section 9.4.2(b) will be allocated first to the costs and expenses of the Party taking such action, and second, to the costs and\nexpenses (if any) of the other Party, with any remaining amounts (if any) to be allocated as follows: (i) for a suit, action or proceeding controlled by",
  "parties": "15.14  No Third Party Beneficiaries.  No person or entity other than Aimmune, Xencor and their respective Affiliates, successors and permitted\nassignees hereunder, shall be deemed an intended beneficiary hereunder or have any right to enforce any obligation of this Agreement.\n15.15  Independent Contractors.  It is expressly agreed that Aimmune and Xencor shall be independent contractors and that the relationship\nbetween Aimmune and Xencor shall not constitute a partnership, joint venture or agency. Neither Aimmune nor Xencor shall have the authority to make\nany statements, representations, or commitments of any kind, or to take any action, which shall be binding on the other Party, without the prior written\nconsent of such other Party.\n15.16  Counterparts\u037e Facsimile Signatures.  This Agreement may be executed in three (3) or more counterparts, each of which shall be deemed an\n\nbecomes the owner of all or substantially all of the business and assets of (y) such Party or (z) that portion of such Party\u2019s business or business unit\nrelating to this Agreement. Any permitted successor or assignee of rights or obligations hereunder shall, in a writing delivered to the other Party,\nexpressly assume the performance of such rights or obligations. Except as set forth in the immediately preceding sentence, in the event of an assignment\nor transfer as permitted above in this Section 15.6, the assigning or transferring Party shall remain responsible (jointly and severally) with such Affiliate\nfor the\n45\nSource: AIMMUNE THERAPEUTICS, INC., 8-K, 2/5/2020\n\n(c) Cooperation\u037e Damages.\n(i) If one Party brings any suit, action or proceeding under Section 9.4.2(b), the other Party agrees to be joined as party\nplaintiff if necessary to prosecute the suit, action or proceeding and to give the first Party reasonable authority to file and prosecute the suit, action or\nproceeding\u037e provided, however, that neither Party will be required to transfer any right, title or interest in or to any property to the other Party or any\nother party to confer standing on a Party hereunder without the first Party\u2019s consent, not to be unreasonably withheld, conditioned or delayed.\n(ii) The Party not pursuing the suit, action or proceeding hereunder will provide reasonable assistance to the other Party,\nincluding by providing access to relevant documents and other evidence and making its employees available, subject to the other Party\u2019s reimbursement\nof any costs incurred by the non-enforcing  or defending Party in providing such assistance.\n\nconstitutes a legal, valid, and binding obligation of such Party that is enforceable against it in accordance with its terms, except as enforcement may be\naffected by bankruptcy, insolvency or other similar laws and by general principles of equity.\n10.1.3  No Conflicts.  The execution, delivery and performance of this Agreement by it does not (i) conflict with any agreement, instrument\nor understanding, oral or written, to which it is a party and by which it may be bound or (ii) violate any Applicable Law.\n10.1.4  All Consents and Approvals Obtained.  Except with respect to Regulatory Approvals for the Development, Manufacturing or\nCommercialization of the Product or as otherwise described in this Agreement, (i) all necessary consents, approvals and authorizations of, and (ii) all\nnotices to, and filings by such Party with, all Governmental Authorities and other Persons required to be obtained or provided by such Party as of the",
  "key_terms": "15.2 Entire Agreement\u037e Amendment. This Agreement, together with the Schedules and Exhibits hereto, contains the entire understanding of the\nParties with respect to the subject matter hereof. Any other express or implied agreements and understandings, negotiations, writings and commitments,\neither oral or written, in respect to the subject matter hereof are superseded by the terms of this Agreement. The Schedules and Exhibits to this\nAgreement are incorporated herein by reference and shall be deemed a part of this Agreement. This Agreement may be amended, or any term hereof\nmodified, only by a written instrument duly executed by authorized representatives of each of the Parties.\n15.3 Force Majeure. No Party shall be liable for any failure to perform, or be considered in breach of, its obligations under this Agreement (other\nthan obligations to make payments of money) to the extent such performance has been delayed, interfered with or prevented by an event of Force\n\nconstitutes a legal, valid, and binding obligation of such Party that is enforceable against it in accordance with its terms, except as enforcement may be\naffected by bankruptcy, insolvency or other similar laws and by general principles of equity.\n10.1.3  No Conflicts.  The execution, delivery and performance of this Agreement by it does not (i) conflict with any agreement, instrument\nor understanding, oral or written, to which it is a party and by which it may be bound or (ii) violate any Applicable Law.\n10.1.4  All Consents and Approvals Obtained.  Except with respect to Regulatory Approvals for the Development, Manufacturing or\nCommercialization of the Product or as otherwise described in this Agreement, (i) all necessary consents, approvals and authorizations of, and (ii) all\nnotices to, and filings by such Party with, all Governmental Authorities and other Persons required to be obtained or provided by such Party as of the\n\narbitration or litigation. To accomplish this objective, the Parties agree to follow the procedures set forth in this Section 15.1 if and when a Dispute arises\nunder this Agreement. If the Parties are unable to resolve any Dispute within [***] ([***]) days after such Dispute is submitted to it, either Party may, by\nwritten notice to the other Party, have such Dispute referred to Designated Officers of each Party for attempted resolution. In the event the Designated\nOfficers or their delegates are not able to resolve such Dispute within such [***] ([***]) day period after receipt of written notice, then each Party is free\nto pursue any remedy at law or in equity available to such Party consistent with Section 15.13.\n15.2 Entire Agreement\u037e Amendment. This Agreement, together with the Schedules and Exhibits hereto, contains the entire understanding of the\n\nof the jurisdiction in which it is incorporated, and has full corporate power and authority and the legal right to own and operate its property and assets\nand to carry on its business as it is now being conducted and as contemplated in this Agreement, including the right to grant the licenses granted by it\nhereunder.\n10.1.2  Authority and Binding Agreement. (i) It has the corporate power and authority and the legal right to enter into this Agreement and\nperform its obligations hereunder, (ii) it has taken all necessary corporate action on its part required to authorize the execution and delivery of this\nAgreement and the performance of its obligations hereunder, and (iii) this Agreement has been duly executed and delivered on behalf of such Party, and\nconstitutes a legal, valid, and binding obligation of such Party that is enforceable against it in accordance with its terms, except as enforcement may be"
}